NCT02087904View on ClinicalTrials.gov

A Study Evaluating the Safety, Efficacy, and Pharmacodynamic Effects of ABT-981 in Patients With Knee Osteoarthritis

PHASE2CompletedINTERVENTIONAL
Enrollment

350

Participants

Timeline

Start Date

June 4, 2014

Primary Completion Date

June 7, 2016

Study Completion Date

December 13, 2016

Conditions
Knee OsteoarthritisMedial Compartment Knee Osteoarthritis
Interventions
BIOLOGICAL

ABT-981

OTHER

Placebo

Sponsors

Lead Sponsor

AbbVie
All Listed Sponsors
lead

AbbVie

INDUSTRY